ISP Investments LLC signed an agreement to acquire Global Exclusive Manufacturing Rights to Vital ET® and TPM® for Personal Care from Avecho Biotechnology Limited (ASX:AVE) for approximately AUD 3.5 million on June 20, 2019. Under the agreement, Ashland Global Holdings Inc. (NYSE:ASH), parent of ISP Investments LLC, will also acquire all Avecho’s interests in the Vital ET®. Avecho has also granted Ashland a right of first refusal in relation to the relevant manufacturing patents, which allows Ashland to submit a matching offer in the event Avecho receives an offer from a third party to acquire the patents. Avecho retains the rights to manufacture TPM® for human and animal health applications.